CALLE DOCTOR FLEMING, 51 | 28036 MADRID, SPAIN
+34 91 3459395
info@oxonepi.com

STUDIES

Studies

“We support pharmaceutical companies to effectively meet the growing data requirements of late-phase studies for better outcomes or greater value”

Our ethos is to encourage original scientific thought and innovation so that projects benefit from the best design and execution.

1

FIELD STUDIES

We work seamlessly with our partner’s late phase division to ensure that the especial requirements of observational research are met in the most cost-effective way.

2

SECONDARY DATABASE STUDIES

We have direct experience in many countries and we understand that matching research objectives with the capabilities of local data sources is an essential step in undertaking valid and credible research.

3

HYBRID STUDIES

We combine specific elements of study designs to maximise the quality of the study output. Bespoke study designs mixing quantitative and qualitative data, tailored to the study objectives.

OBSERVATIONAL FIELD STUDIES

We offer multi country field studies of health in populations (Cohort Studies, Case Control Studies and Cross-Sectional Studies) to understand the causes and patterns of health and illness.

DATABASE STUDIES

OXON provides clients with single and multi-country database studies to offer information that helps to shape cost-saving measures or to improve the health care.

HYBRID STUDIES

OXON supports sponsors to fill evidence gaps and to generate RWE through hybrid approaches. We combine specific study designs to maximise the accuracy of the study and generate high quality data.

Study designs

OXON provides a unique blend of observational science and operational excellence to our clients as fellow scientists

At OXON we advise clients frankly on the advantages and disadvantages of their study options while  our experts help determine the right type of study according to the time, cost, and regulatory implications. 

""

PASS & PAES STUDIES

We assist our clients in designing and conducting post-authorisation safety/efficacy studies, always under the ENCePP guide on methodological standards in pharmacoepidemiology and Code of Conduct.

""

PATIENT-REPORTED OUTCOMES

We specialise in the use of PROs within observational studies and support clients with the design, implementation, analysis, and interpretation of the data on patients in real life situations.  

""

DISEASE/DRUG REGISTRIES

Patient registries provide a real-world view of clinical practice, patient outcomes, safety, comparative and cost-effectiveness, and serve to evidence development and decision-making purposes.

""

RISK MINIMISATION STUDIES

OXON delivers studies measuring the effectiveness of risk minimization measures (RMMs) and the evaluation of their effectiveness for products from various disease areas and global risk minimisation approaches.

""

SYSTEMATIC REVIEWS
& META-ANALYSIS

We use systematic methods to collect secondary data to appraise and synthesise the best available evidence on a defined question and offer statistical approaches to combining the data derived from any systematic review.

""

HEOR

We specialise in the use of health economics within observational studies from a patient centred approach to help collect the evidence needed to prove the cost-effectiveness of any given drug and address stakeholder evidence requests.

Contact us! It will only take a minute

CONTACT US